AR128632A1 - Anticonceptivo oral masticable de drospirenona - Google Patents

Anticonceptivo oral masticable de drospirenona

Info

Publication number
AR128632A1
AR128632A1 ARP230100477A ARP230100477A AR128632A1 AR 128632 A1 AR128632 A1 AR 128632A1 AR P230100477 A ARP230100477 A AR P230100477A AR P230100477 A ARP230100477 A AR P230100477A AR 128632 A1 AR128632 A1 AR 128632A1
Authority
AR
Argentina
Prior art keywords
drospirenone
oral contraceptive
chewable oral
oral
relates
Prior art date
Application number
ARP230100477A
Other languages
English (en)
Inventor
Enrico Colli
Jean Bonny
- Urek Sandra Daniel
De La Cruz Maria Ngeles Prez
Original Assignee
Chemo Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Res S L filed Critical Chemo Res S L
Publication of AR128632A1 publication Critical patent/AR128632A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al campo de composiciones farmacéuticas orales y a su uso para proporcionar anticoncepción. Más específicamente, la presente invención se refiere a comprimidos masticables orales de drospirenona, a su uso para proporcionar anticoncepción a un individuo y a un kit que comprende unidades de dosificación diarias de tales comprimidos masticables orales.
ARP230100477A 2022-03-01 2023-02-28 Anticonceptivo oral masticable de drospirenona AR128632A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22382182 2022-03-01

Publications (1)

Publication Number Publication Date
AR128632A1 true AR128632A1 (es) 2024-05-29

Family

ID=80625242

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230100477A AR128632A1 (es) 2022-03-01 2023-02-28 Anticonceptivo oral masticable de drospirenona

Country Status (3)

Country Link
AR (1) AR128632A1 (es)
TW (1) TW202345855A (es)
WO (1) WO2023165988A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
US6667050B1 (en) 1999-04-06 2003-12-23 Galen (Chemicals) Limited Chewable oral contraceptive
JP4354667B2 (ja) * 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
WO2009132208A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US9603860B2 (en) * 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same

Also Published As

Publication number Publication date
TW202345855A (zh) 2023-12-01
WO2023165988A1 (en) 2023-09-07

Similar Documents

Publication Publication Date Title
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
NO20081038L (no) Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
ES2164940T3 (es) Forma de dosificacion solida bioadhesiva.
CR8717A (es) Nuevos compuestos
CO6400186A2 (es) Tabletas de acetato de ulipristal
EA200901393A1 (ru) Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат
CO6640305A2 (es) Elaboración de gránulos sin activos y tabletas que comprenden los mismos
BRPI0512263A (pt) formulações de liberação imediata de formas de dosagem oral de memantina
AR049065A1 (es) Forma de administracion para la contracepcion hormonal
WO2020044119A3 (en) Oral formulations of lavender and cannabinoids
PE20211588A1 (es) Compuestos y sus usos para aliviar sintomas asociados a la menopausia
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
SI2906233T1 (en) Pharmaceutical forms for the treatment and prevention of obesity
AR065816A1 (es) Regimen anticonceptivo oral
AR049196A1 (es) Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona
AR128632A1 (es) Anticonceptivo oral masticable de drospirenona
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
BRPI0513566A (pt) composição farmacêutica compreendendo gabapentina
AR065971A1 (es) Nuevo regimen de drosperinona/17beta-estradiol, producto farmaceutica combinado y conjunto de elementos (kit) para su aplicacion
CO2022014548A2 (es) Forma de dosificación oral sólida que comprende pomalidomida
BR112024001927A2 (pt) Formas de dosagem gastrorretentivas de 5-hidroxitriptofano
EA200701091A1 (ru) Противозачаточный фармацевтический препарат
CL2008003919A1 (es) Compuestos derivados de y-lactona del acido 15a,16a-metilen-17-hidroxi-19-nor-17-pregna-4-en-3-ona-21-carboxilico; composicion farmaceutica que lo contiene y su uso para preparar medicamento para la contracepcion oral y para trastornos pre, peri y postmenopausicos.
CL2008003921A1 (es) Compuestos derivados de 15,16-metilen-17-(1'-propenil)-17-3'-xidoestra-4-en-3-ona, composicion farmaceutica que los contiene y su uso para preparar un medicamento para la contracepcion oral y para trastornos pre, peri y post-menopausicos.
CO2019014831A2 (es) Nuevas formulaciones orales de belinostat